Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$72.92 - $102.01 $196,884 - $275,427
-2,700 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $150,525 - $250,425
2,700 New
2,700 $235,000
Q1 2020

May 08, 2020

SELL
$37.9 - $104.44 $102,330 - $281,988
-2,700 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$90.37 - $122.49 $9,037 - $12,249
-100 Reduced 3.57%
2,700 $244,000
Q1 2019

Apr 30, 2019

BUY
$61.98 - $96.5 $173,544 - $270,200
2,800 New
2,800 $243,000
Q4 2018

Feb 06, 2019

SELL
$56.04 - $82.66 $156,912 - $231,448
-2,800 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$48.29 - $80.6 $135,212 - $225,679
2,800 New
2,800 $221,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.89B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mogy Joel R Investment Counsel Inc Portfolio

Follow Mogy Joel R Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mogy Joel R Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mogy Joel R Investment Counsel Inc with notifications on news.